Effects of 24 Weeks of Lansoprazole Therapy on Asthma Symptoms, Exacerbations, Quality of Life, and Pulmonary Function in Adult Asthmatic Patients With Acid Reflux Symptoms
Authors:
- Michael R. LittnerMLMichael R. Littner
- Felix W. LeungFLFelix W. Leung
- E. David BallardEBE. David Ballard
- Bidan HuangBHBidan Huang
- Nina K. SamraNSNina K. Samra
- 1 September 2005
- Vol. 128 (3) , 1128-1135
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Similarities and Differences in Asthma and Chronic Obstructive Pulmonary Disease ExacerbationsProceedings of the American Thoracic Society, 2004
- Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of SeretideTM (50/250 μg bd DiskusTM vs. formoterol (12 μg bd) and budesonide (800 μg bd) given concurrently (both via TurbuhalerTM) in patients with moderate-to-severe asthmaRespiratory Medicine, 2002
- Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trialThe Lancet, 2001
- Gastroesophageal Reflux in AsthmaticsChest, 1999
- 24-h Esophageal pH Testing in AsthmaticsChest, 1999
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- A controlled assessment of an asthma self-management plan involving a budesonide dose regimen. OPTIONS Research GroupEuropean Respiratory Journal, 1996
- Asthma and gastroesophageal reflux: Acid suppressive therapy improves asthma outcomeThe American Journal of Medicine, 1996
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994
- Medical and Surgical Treatment of Nonallergic Asthma Associated with Gastroesophageal RefluxChest, 1991